Kevin Robison

Kevin Robison co-founded and has led the Childhood Cancer Survivor Study since its inception, building the world's largest and most productive cohort for studying late effects of childhood cancer treatment. His epidemiological research spanning decades has documented the full spectrum of treatment-related morbidity and mortality in survivors, from secondary malignancies to organ-specific toxicities. His methodological innovations in survivorship cohort design and follow-up have established the framework used by survivorship studies globally.